11 Jan 2022
GHO Capital invests in RoslinCT, a leading cell therapy CDMO
Press Release
Read storyMembers' News
10 Dec 2021
Medannex presents data on new therapy showing powerful synergy with common cancer treatments
Medannex’s new therapy shows powerful synergy with common cancer treatments
Read story9 Dec 2021
103.5 million pounds raised by Ideagen Plc to bolster international growth plans
Leading global provider of information management software, Ideagen Plc, has today announced that it has raised £103.5 million to accelerate product investment and scale global operations through further acquisitions.
Read story8 Dec 2021
NovaBiotics Announces First Patient Enrollment into the Cysteamine Domain of REMAP-CAP
NovaBiotics Announces First Patient Enrollment into the Cysteamine Domain of REMAP-CAP
Read story17 Nov 2021
ResMed Invests in Lenus Health, Recent Winner of NHSX AI Health and Care Award
ResMed Invests in Lenus Health, Recent Winner of NHSX AI Health and Care Award
Read story6 Sep 2021
ILC Therapeutics announces successful completion of 3.5M funding round
PRESS RELEASE (Issued on behalf of ILC Therapeutics)
Read story17 Aug 2021
Alba Science joins Eurofins Scientific
Alba Science is pleased to announce that it has joined the Eurofins Scientific Group.
Read story11 Aug 2021
Q2 Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK
For further details click here
Read story10 Aug 2021
Valid Insight is joining the Bioscript group.
Valid Insight are delighted to announce that we are joining the Bioscript group.
Read story19 Jul 2021
Tissue Solutions has been Acquired by BioIVT
For more information click here!
Read story29 Jun 2021
Cell and Gene Therapy Catapult to expand to Edinburgh BioQuarter
The Cell and Gene Therapy Catapult (CGT Catapult) today announces that it will establish offices and laboratories in Edinburgh, Scotland. With this expansion CGT Catapult aims to provide additional, regionally focused s…
Read story21 Jun 2021
NovaBiotics Announces Cysteamine Bitartrate (NM002) Included in REMAP-CAP Phase 3 Clinical Trial
NovaBiotics Announces Cysteamine Bitartrate (NM002) Included in REMAP-CAP Phase 3 Clinical Trial for Community Acquired Pneumonia
Read story16 Jun 2021
Storm ID awarded Artificial Intelligence in Health and Care Award by UK Government for innovative CO
Scottish digital transformation consultancy Storm ID has been successful in the latest round of the ‘Artificial Intelligence in Health and Care Award’, for a service which uses artificial intelligence to help patients w…
Read story3 Jun 2021
Cellexus receive grant to expand product range
PRESS RELEASE
Read story1 Jun 2021
Novabiotics announces publication of NP339's Broad Antifungal Activity
NovaBiotics Announces Publication of Data Elucidating NP339’s Broad Antifungal Activity in Antimicrobial Agents and Chemotherapy
Read story